Summary
In this randomized, multicentric trial, patients with functional constipation received either polyethylene glycol (PEG) or lactulose for 12 weeks and were subsequently followed for 4 weeks. The primary outcome variables were the number of defecations per week after 12 weeks of treatment, and improvement in stool consistency of at least 2 points in the Bristol scale. Bowel movements ≥3 per week and stool consistency ≥2 (Bristol scale) were considered as successful treatment. Investigators enrolled 102 patients with mean (SD) age of 3.62 (1.42) years, out of which 88 completed the study. The mean (SD) number of defecations per week was more in PEG group as compared to the lactulose group (7.9 (0.6) vs 5.7 (0.5), P=0.008). Both groups had similar frequency of painful defecation, stool retention, large volume of stools, and hard stools. There were more patients with side effects of bloating and abdominal pain in the lactulose group (23 vs 15, P=0.02). The authors concluded that PEG 3350 is more effective and causes fewer side effects compared to lactulose in the treatment of constipation in infants and children.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, et al. PEG 3350 versus lactulose for treatment of functional constipation in children: randomized study. J Pediatr Gastroenterol Nutr. 2019;68:318–24.
Cochrane Risk of Bias Tool (modified) for Quality Assessment of Randomized Controlled Trials. Available from: http://www.tc.umn.edu/~msrg/caseCATdoc/rct.crit.pdf. Accessed July 14, 2017.
No authors listed. Efficacy of Dicopeg Junior in comparison with lactulose for the treatment of functional constipation in children aged 6 months to 6 years. Available from:https://www.clinicaltrials.gov/ct2/show/NCT03177434?intr=Dicopeg+Junior &rank=1. Accessed: April 15, 2019.
Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58: 258–74.
Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;8:CD009118.
Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut. 2004;53: 1590–4.
Treepongkaruna S, Simakachorn N, Pienvichit P, Magis A, Garnier P, Maisonobe P, et al. Efficacy of a polyethylene glycol laxative (PEG, Macrogol 4000) versus lactulose for the treatment of chronic constipation in children. Results of a randomized, double-blind controlled study performed in Thailand. Gastroenterology. 2013;144:S547.
Dupont C, Leluyer B, Maamri N, Morali A, Joye J, Fiorini J, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr. 2005;41:625–33.
Saneian H, Mostofizadeh N. Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulose in treatment of functional constipation in children. J Res Med Sci. 2012;17:S145–9.
Fordtran JS, Hofmann AF. Seventy years of polyethylene glycols in gastroenterology: The journey of peg 4000 and 3350 from nonabsorbable marker to colonoscopy preparation to osmotic laxative. Gastroenterology. 2017; 152: 675–80.
Bekkali NLH, Hoekman DR, Liem O, Bongers MEJ, van Wijk MP, Zegers B, et al. Polyethylene glycol 3350 with electrolytes versus polyethylene glycol 4000 for constipation: a randomized, controlled trial. J Pediatr Gastroenterol Nutr. 2018;66:10–15.
Poddar U. Approach to constipation in children. Indian Pediatr. 2016;53:319–27.
Yachha SK, Srivastava A, Mohan N, Bharadia L, Sarma MS; for the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition Committee on Childhood Functional Constipation, and Pediatric Gastroenterology Subspecialty Chapter of Indian Academy of Pediatrics. Management of Childhood Functional Constipation: Consensus Practice Guidelines of Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition and Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics. Indian Pediatr. 2018;55:885–92.
References
Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, et al. PEG 3350 versus lactulose for treatment of functional constipation in children: randomized study. J Pediatr Gastroenterol Nutr. 2019;68:318–24.
Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and fecal impaction: a systematic review. Arch Dis Child. 2009;94:156–60.
Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG. osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2016;8:CD009118.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mathew, J.L., Bhatnagar, S. Polyethylene Glycol vs. Lactulose in Infants and Children with Functional Constipation. Indian Pediatr 56, 415–419 (2019). https://doi.org/10.1007/s13312-019-1539-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-019-1539-x